Cargando…

Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer

Cyclin-dependent kinase 9 (CDK9) activity is correlated with worse outcomes of triple-negative breast cancer (TNBC) patients. The heterodimer between CDK9 with cyclin T1 is essential for maintaining the active state of the kinase and targeting this protein–protein interaction (PPI) may offer promisi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Sha-Sha, Qu, Yuan-Qing, Wu, Jia, Yang, Guan-Jun, Liu, Hao, Wang, Wanhe, Huang, Qi, Chen, Feng, Li, Guodong, Wong, Chun-Yuen, Wong, Vincent Kam Wai, Ma, Dik-Lung, Leung, Chung-Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069406/ https://www.ncbi.nlm.nih.gov/pubmed/35530158 http://dx.doi.org/10.1016/j.apsb.2021.10.024

Ejemplares similares

Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
por: Cheng, Shasha, et al.
Publicado: (2021)

The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury
por: Li, Guodong, et al.
Publicado: (2021)

Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
por: Yang, Chao, et al.
Publicado: (2017)

Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
por: Li, Guodong, et al.
Publicado: (2023)

A long-lived peptide-conjugated iridium(iii) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2
por: Vellaisamy, Kasipandi, et al.
Publicado: (2018)

A small molecule HIF-1α stabilizer that accelerates diabetic wound healing
por: Li, Guodong, et al.
Publicado: (2021)

Molecular docking analysis of piperine with CDK2,CDK4,Cyclin D and Cyclin T proteins
por: Rekha, Umapathy Vidhya, et al.
Publicado: (2020)

Luminescent Iridium(III) Chemosensor for Tandem Detection of F(–) and Al(3+)
por: Liu, Jin-Biao, et al.
Publicado: (2017)

Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages
por: Cao, Lihuan, et al.
Publicado: (2014)

The awakening of the CDK10/Cyclin M protein kinase
por: Guen, Vincent J., et al.
Publicado: (2017)

Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9
por: Li, Guodong, et al.
Publicado: (2022)

Antagonizing STAT5B dimerization with an osmium complex
por: Liu, Li-Juan, et al.
Publicado: (2016)

Interference reduction isothermal nucleic acid amplification strategy for COVID-19 variant detection
por: Li, Guodong, et al.
Publicado: (2023)

Luminescent chemosensors by using cyclometalated iridium(iii) complexes and their applications
por: Ma, Dik-Lung, et al.
Publicado: (2017)

Cyclin B/CDK1 and Cyclin A/CDK2 phosphorylate DENR to promote mitotic protein translation and faithful cell division
por: Clemm von Hohenberg, Katharina, et al.
Publicado: (2022)

A Ruthenium(II) Complex Supported by Trithiacyclononane and Aromatic Diimine Ligand as Luminescent Switch-On Probe for Biomolecule Detection and Protein Staining
por: Wong, Chun-Yuen, et al.
Publicado: (2014)

Temporal changes in cyclinD-CDK4/CDK6 and cyclinE-CDK2 pathways: implications for the mechanism of deficient decidualization in an immune-based mouse model of unexplained recurrent spontaneous abortion
por: Chang, Zhuo, et al.
Publicado: (2022)

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
por: Kryštof, Vladimír, et al.
Publicado: (2012)

Recent Progress and Development of G-Quadruplex-Based Luminescent Assays for Ochratoxin A Detection
por: Nao, Sang-Cuo, et al.
Publicado: (2020)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease
por: Cheng, Shasha, et al.
Publicado: (2022)

Aurone derivatives as Vps34 inhibitors that modulate autophagy
por: Li, Guodong, et al.
Publicado: (2019)

Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
por: Liu, Li-Juan, et al.
Publicado: (2016)

Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
por: Rajput, Sandeep, et al.
Publicado: (2016)

Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect
por: Wu, Chun, et al.
Publicado: (2020)

A label-free G-quadruplex-based mercury detection assay employing the exonuclease III-mediated cleavage of T–Hg(2+)–T mismatched DNA
por: Wang, Wanhe, et al.
Publicado: (2015)

Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
por: Leung, Chung-Hang, et al.
Publicado: (2019)

SOX9 interacts with FOXC1 to activate MYC and regulate CDK7 inhibitor sensitivity in triple-negative breast cancer
por: Tang, Lin, et al.
Publicado: (2020)

Nuclear Import of Cdk/Cyclin Complexes: Identification of Distinct Mechanisms for Import of Cdk2/Cyclin E and Cdc2/Cyclin B1
por: Moore, Jonathan D., et al.
Publicado: (1999)

Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies
por: Ma, Dik-Lung, et al.
Publicado: (2019)

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding
por: Faber, Erik B., et al.
Publicado: (2023)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2018)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
por: Zhang, Wengang, et al.
Publicado: (2023)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
por: Funamoto, Masafumi, et al.
Publicado: (2022)

MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding
por: Asamitsu, Kaori, et al.
Publicado: (2017)

Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders
por: Kawauchi, Takeshi, et al.
Publicado: (2013)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j6kjeiq9s2pcshut0ph87knmp3